Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
VSTM
#2622
Verastem, Inc.
5.7
2
+1.42%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
+1.42%
Variazione Mensile
-11.86%
Variazione di 6 mesi
-38.49%
Variazione Annuale
+6.32%
Chiusura Precedente
5.6
4
Open
5.7
2
Bid
Ask
Low
5.7
2
High
5.7
2
Volume
58
Mercati
Mercato Azionario Statunitense
Salute
VSTM
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
Verastem Inc
Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.
Notizie
What Makes Verastem (VSTM) a New Buy Stock
Verastem Stock Rises Nearly 8% on Strong Q4 & 2025 Preliminary Results
B.Riley riconferma il rating Buy per le azioni Verastem, mantiene target a $16
B.Riley reiterates Buy rating on Verastem stock, maintains $16 target
Verastem riporta 17,5 milioni di dollari di ricavi nel Q4 per trattamento oncologico
Verastem reports $17.5 million in Q4 revenue for cancer treatment
Verastem stock rating initiated at Buy by H.C. Wainwright with $18 target
Immuneering: Strong Buy Despite Decline In Share Price On Atebimetinib Data (NASDAQ:IMRX)
Revolution Medicines stock surges over 20% on potential AbbVie acquisition
Il titolo di Revolution Medicines balza oltre il 20% su possibile acquisizione AbbVie
What's Going On With Verastem Stock Friday? - Verastem (NASDAQ:VSTM)
Azioni Verastem stabili mentre Mizuho riconferma rating Outperform